NRIX ข่าวฟอเร็กซ์
Nurix Therapeutics Says Gilead Sciences Extends Ongoing Strategic Collaboration By Addl. Two Years
Biopharmaceutical company Nurix Therapeutics, Inc. (NRIX) announced Tuesday that Gilead Sciences, Inc. (GILD) has elected to extend the research term of the companies' ongoing collaboration, originally established in 2019, by an additional two years.
RTTNews
|
200 วันที่ผ่านมา
Gilead Exercises Option To License Nurix's Protein Degrader Molecule NX-0479
Biopharmaceutical companies Gilead Sciences, Inc. (GILD) and Nurix Therapeutics, Inc. (NRIX) announced Monday that Gilead has exercised its option to exclusively license Nurix's investigational targeted protein degrader molecule NX-0479.
RTTNews
|
579 วันที่ผ่านมา
